Street Calls of the Week
Investing.com - BMO Capital downgraded W.R. Berkley (NYSE:WRB) from Market Perform to Underperform on Wednesday, setting a price target of $64.00. The insurance giant, with a market capitalization of $28.5 billion, has demonstrated strong financial performance with a 28% gain year-to-date and maintains an impressive 51-year streak of consecutive dividend payments.
The downgrade reflects BMO’s expectation of a "re-coupling of WRB’s decelerating fundamentals with current relatively expensive valuation levels" by March 2026. According to InvestingPro analysis, the stock currently trades at a P/E ratio of 17.1x and shows signs of being slightly undervalued based on comprehensive Fair Value calculations.
BMO noted that W.R. Berkley’s current valuation appears to be supported by expectations that Mitsui Sumitomo Insurance will continue accumulating shares in the open market through March.
While this factor is likely to continue influencing the stock price in the near term, BMO emphasized that Mitsui’s ownership stake "does not warrant a takeout premium to be embedded within WRB’s valuation."
The research firm maintained its $64.00 price target for the insurance company’s shares alongside the rating downgrade.
In other recent news, W.R. Berkley reported its third-quarter earnings per share, which were mostly in line with expectations but slightly missed some analysts’ projections. The earnings were impacted by catastrophe losses and lower net investment income. Truist Securities raised its price target for W.R. Berkley to $84, maintaining a Buy rating, highlighting the company’s ability to meet expectations despite these challenges. UBS also maintained a Buy rating with a price target of $87, though it noted a potential neutral to modestly negative reaction due to slowing premium growth and cautious pricing commentary. Cantor Fitzgerald reiterated its Overweight rating with a price target of $82, emphasizing W.R. Berkley’s favorable positioning compared to peers. On a different note, Wells Fargo lowered its price target to $66, citing a miss in earnings per share and weaker growth. Similarly, Jefferies reduced its price target to $75, maintaining a Hold rating, following the company’s earnings miss against their estimates and the consensus. These recent developments reflect varied analyst perspectives on W.R. Berkley’s financial performance and growth outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.